Skip to main content

Guggul

Scientific Name(s): Commiphora mukul Hook. ex Stocks., Commiphora wightii (Arn.) Bhandari
Common Name(s): Guggal, Guggul, Guggulu, Gugulipid, Gum guggal, Gum guggulu, Indian bdellium, Indian myrrh

Medically reviewed by Drugs.com. Last updated on Dec 23, 2024.

Clinical Overview

Use

Guggul has been used in the traditional Ayurvedic medical system for centuries and has been studied extensively in India. Commercial products are promoted for use in hyperlipidemia; however, clinical studies do not substantiate this claim. Anti-inflammatory and cardiovascular effects are being evaluated, as well as use in cancer, obesity, and diabetes.

Dosing

Clinical trials are lacking to provide dosage guidelines; however, in a US clinical trial of hyperlipidemia, 75 to 150 mg of standardized guggulsterones were administered daily. In a study evaluating the anti-inflammatory effect of guggul, 500 mg of gum guggul was taken 3 times per day.

Contraindications

None identified. Caution may be warranted in patients previously experiencing adverse effects to statins.

Pregnancy/Lactation

Information regarding safety and efficacy in pregnancy and lactation is lacking.

Interactions

None well documented.

Adverse Reactions

Although generally accepted as relatively safe, case reports of adverse events exist. Moderate to severe generalized acute eczematous reactions to oral guggul have been reported, and caution may be warranted. A case report exists of rhabdomyolysis possibly caused by guggul consumption.

Toxicology

Research reveals little information regarding toxicology with the use of guggul.

Scientific Family

Botany

The guggul plant is widely distributed throughout India and adjacent dry regions. The tree is a small shrub with thorny branches. The gum, called "guggul" or "gum guggulu," is tapped from the stem of the plant, and the fragrant yellow latex solidifies as it oozes out. Excessive production of the gum eventually kills the plant. C. mukul is synonymous with Commiphora wightii and is in the same genus as Commiphora myrrha, the myrrh mentioned in the Bible.1, 2

History

The plant has been used in the traditional Ayurvedic medical system for centuries in the treatment of a variety of disorders, most notably arthritis, and as a weight-reducing agent in obesity. Other traditional uses have included liver dysfunction, tumors, ulcers and sores, urinary complaints, intestinal worms, edema, seizures, and as a cardiac tonic. In 1966, the first medical studies in animals were conducted, and in 1986, guggal was approved for marketing in India as a hypolipidemic drug. A commercial product, Guggulow, claiming cholesterol-lowering properties, is widely available on the internet.2, 3, 4

Chemistry

Guggul is the dry gum resin obtained from incisions in the bark of the Commiphora mukul tree as well as Commiphora molmol, Commiphora abyssinica, and Commiphora burseraceae.69 The gum contains minerals, resin, volatile oils, sterols, ferulates, flavones, sterones, and other chemical constituents.

Several pharmacologically active components have been identified in the plant, including guggulsterone (E- and Z-stereoisomers) and gugulipid, both found in the ethyl acetate extract of the plant. Studies have shown that the guggulsterones are antagonist ligands for the bile acid receptor farnesoid X receptor, which is activated by bile salts, thus reducing cholesterol. A triterpene, myrrhanol A, has been described to have potent anti-inflammatory effects. High-performance liquid chromatography and thin-layer chromatography methods for standardization have been described, and adulterants have been found in commercial preparations.2, 5, 6, 7, 8, 9, 10, 11, 12, 13

Uses and Pharmacology

Acne

One small study has shown guggulsterone to be as effective as tetracycline in the treatment of nodulocystic acne.(55) In vitro antibacterial effects have been described.(16)

Anti-inflammatory effects

Down-regulation of the expression of inflammatory mediators, including interleukins, transcription factors and cytokines, and hyaluronidase and collagenase enzymes have been demonstrated for extracts of C. mukul.(4, 14, 15, 16, 17, 18)

Animal data

Extracts of the plant have anti-inflammatory action and inhibit carrageenan-induced rat paw edema in animal models. Guggul was as effective as phenylbutazone and ibuprofen in an animal model of acute and chronic inflammation.(11, 19, 20, 21)

In mice with induced colitis, guggulsterone decreased the severity of the inflammatory disease.(16, 22) In rats with induced uveitis, guggulsterone demonstrated a protective effect against inflammatory mediators.(23)

Clinical data

A clinical study conducted in 30 elderly patients with osteoarthritis of the knee showed significant improvement in the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and visual analog scores after taking 500 mg of C. mukul (guggulsterone 3.5%) 3 times daily with food. However, not all outcome measures showed improvement at the 2-month point.(24) Clinical studies in GI inflammatory disease are lacking.

Cancer

Animal data

In vitro studies have evaluated the effect of C. mukul extracts in a wide variety of cancer cell lines, including leukemia, myeloma, and head and neck, lung, breast, ovarian, prostate, skin, and bone cancers.(2, 25, 26, 27, 28, 29, 30, 31, 32, 33) Induction of apoptosis and inhibition of angiogenesis and cell signaling, as well as the down-regulation of transcription factors, have all been demonstrated.

Cardiac effects

Animal data

In rats with isoproterenol-induced ischemia, a hydroalcoholic extract of C. mukul improved cardiac function and prevented myocardial ischemic impairment.(34) Guggulsterone also exerts a protective effect on cardiac enzymes against drug-induced myocardial necrosis.(35)

Clinical data

In an older trial, C. mukul in combination with Inula racemosa (another Ayurvedic botanical) was studied in 200 patients with ischemic heart disease and found to improve electrocardiogram readings and decrease episodes of dyspnea and chest pain.(36) Gum guggul fraction increased fibrinolytic activity and decreased platelet adhesiveness.(37) However, there were no adverse effects on hemodynamic parameters in a safety study.(2)

Dementia

Animal data

Positive effects on neuroinflammation, memory impairment, and dementia-related memory deficit in animal models suggest potential benefits in Alzheimer disease dementia. Effects appear to result from disruption in amyloid protein processing via cholesterol synthesis pathways.(69)

Diabetes

Animal data

In mice with induced diabetes, administration of C. mukul extracts improved glucose tolerance, decreased plasma insulin levels, reduced weight gain, and improved the lipid profile.(38, 39)

Clinical data

Research reveals no clinical trials regarding the use of guggul for diabetes. However, a small trial with 58 adult obese patients demonstrated that diet and guggulu taken over 30 days increased weight loss in patients who weighed more than 90 kg.(40)

Endocrine effects

Animal data

In mice with induced hypothyroidism, coadministration of C. mukul extracts reversed the hypothyroid state and increased triiodothyronine levels in euthyroid animals.(41, 42) In vitro laboratory experiments have shown that guggulsterone is able to bind to mineralocorticoid, glucocorticoid, androgen, and progesterone receptors with either antagonist or agonist action.(43, 44)

Hemorrhoids

A guggul-based kshar sutra ligation was more effective in healing but was less favored than rubber band ligation of hemorrhoids.(56)

Hyperlipidemia

Animal data

Rabbits with induced hyperlipidemia showed decreases of high-density lipoprotein (HDL) and triglycerides after 14 weeks of receiving C. mukul extracts.(45) Studies have shown that the guggulsterones are antagonist ligands for the bile acid receptor farnesoid X receptor, which is activated by bile salts, thus reducing cholesterol.(2, 46)

Clinical data

Limited quality clinical trials have been conducted, with the majority of studies in eastern Indian populations. Reviews of these studies have been published. In most studies, total cholesterol and HDL were reduced. However, in a study conducted in a US population, increases in low-density lipoprotein (LDL) were observed, and case reports of increased LDL with guggul consumption exist. Systematic reviews conducted on herbal medicines used for treatment of cardiovascular conditions, including hyperlipidemia reported the same data for guggul noting reductions as well as increases observed in total and LDL cholesterol, significant decreases in triglycerides, and minor adverse effects.(67, 68) Until larger, long-term quality trials have been conducted and the incidence of adverse events clarified, C. mukul extracts cannot be routinely recommended for the management of hyperlipidemia.(4, 47, 48, 49, 50, 51, 52, 53, 54)

Urinary stones

Studies have demonstrated the ability of C. wightii extracts (synonymous with C. mukul) to inhibit the growth of struvite crystals associated with the development of urinary stone/calculi.(57, 58)

Dosing

Clinical trials are lacking to provide dosage guidelines; however, in a US clinical trial in hyperlipidemia, 75 mg to 150 mg of standardized guggulsterones were administered daily.51 1,000 mg capsules containing 21 mg of guggulsterones were used in this study. In a study evaluating the anti-inflammatory effect of guggul, 500 mg of gum guggul was used 3 times daily.24

Various formulations (eg, tablets, capsules, powders) of guggul are available. Guggul and gugulipid are typically standardized to provide a fixed amount, normally 2.5% or 3.5%, of guggulsterones. However, liquid chromatography has shown commercial over-the-counter products contain less or none of claimed guggulsterone content.6, 7, 13 Standardization of herbal products is warranted.

Pregnancy / Lactation

Information regarding safety and efficacy in pregnancy and lactation is lacking.

Interactions

Diltiazem: Guggul may decrease the serum concentration of diltiazem. Monitor therapy.(60)

Propranolol: Guggul may decrease the serum concentration of propranolol. Monitor therapy.(60)

Adverse Reactions

While the human safety profile of the extract has not been well described for children, pregnant or breast-feeding women, or patients with severe hepatic or renal disease, little to no adverse events have been reported in clinical studies; the adverse effects were primarily GI-related (diarrhea, nausea) as well as cases of hypersensitivity, possible thyroid problems, headache, hiccough, and rash.2, 4, 48, 52, 61, 67

In a study evaluating the effect of oral guggulipid on hyperlipidemia, moderate to severe generalized cutaneous reactions were noted in 9% of participants, leading to dropouts from the study.62 Case reports exist of acute eczematous reactions to guggul-containing creams.63, 64

A case report exists of rhabdomyolysis in a patient taking an extract of C. mukul 300 mg 3 times daily who was previously sensitized (increased creatine kinase) to lipid-lowering statins.59 A similar case report of increased transaminases exists for a combination preparation containing guggulsterol and red yeast rice extract; however, fungal metabolites found in the red yeast rice extract were suspected to be responsible for the adverse effect because the metabolites are structurally similar to lovastatin. The patient had previously experienced hepatotoxicity while taking lovastatin.65 A case report of hepatotoxicity exists for a combination product (fat burner) that included guggul.66

Toxicology

Research reveals little information regarding toxicology with the use of guggul. In rats, dogs, and monkeys, no acute, subacute, or chronic toxicity has been reported. No mutagenesis or teratogenicity has been described for gum guggul.2

Index Terms

References

Disclaimer

This information relates to an herbal, vitamin, mineral or other dietary supplement. This product has not been reviewed by the FDA to determine whether it is safe or effective and is not subject to the quality standards and safety information collection standards that are applicable to most prescription drugs. This information should not be used to decide whether or not to take this product. This information does not endorse this product as safe, effective, or approved for treating any patient or health condition. This is only a brief summary of general information about this product. It does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to this product. This information is not specific medical advice and does not replace information you receive from your health care provider. You should talk with your health care provider for complete information about the risks and benefits of using this product.

This product may adversely interact with certain health and medical conditions, other prescription and over-the-counter drugs, foods, or other dietary supplements. This product may be unsafe when used before surgery or other medical procedures. It is important to fully inform your doctor about the herbal, vitamins, mineral or any other supplements you are taking before any kind of surgery or medical procedure. With the exception of certain products that are generally recognized as safe in normal quantities, including use of folic acid and prenatal vitamins during pregnancy, this product has not been sufficiently studied to determine whether it is safe to use during pregnancy or nursing or by persons younger than 2 years of age.

1. Commiphora mukul. USDA, NRCS. 2007. The PLANTS Database (http://plants.usda.gov, 30 June 2011). National Plant Data Team, Greensboro, NC 70874-4490 USA.
2. Shishodia S, Harikumar KB, Dass S, Ramawat KG, Aggarwal BB. The guggul for chronic diseases: ancient medicine, modern targets. Anticancer Res. 2008;28(6A):3647-3664.19189646
3. Satyavati GV. Gum guggul (Commiphora mukul)—the success story of an ancient insight leading to a modern discovery. Indian J Med Res. 1988;87:327-335.3049326
4. Deng R. Therapeutic effects of guggul and its constituent guggulsterone: cardiovascular benefits. Cardiovasc Drug Rev. 2007;25(4):375-390.18078436
5. Duke JA. CRC Handbook of Medicinal Herbs. Boca Raton, FL: CRC Press; 2002.
6. Mesrob B, Nesbitt C, Misra R, Pandey RC. High-performance liquid chromatographic method for fingerprinting and quantitative determination of E- and Z-guggulsterones in Commiphora mukul resin and its products. J Chromatogr B Biomed Sci Appl. 1998;720(1-2):189-196.9892081
7. Nagarajan M, Waszkuc TW, Sun J. Simultaneous determination of E- and Z-guggulsterones in dietary supplements containing Commiphora mukul extract (guggulipid) by liquid chromatography. J AOAC Int. 2001;84(1):24-28.11234828
8. Cui J, Huang L, Zhao A, et al. Guggulsterone is a farnesoid X antagonist in coactivator association assays but acts to enhance transcription of bile salt export pump. J Biol Chem. 2003;278(12):10214-10220.12525500
9. Urizar NL, Liverman AB, Dodds DT, et al. A natural product that lowers cholesterol as an antagonist ligand for FXR. Science. 2002;296(5573):1703-1706.11988537
10. Wu J, Xia C, Meier J, Li S, Hu X, Lala DS. The hypolipidemic natural product guggulsterone acts as an antagonist of the bile acid receptor. Mol Endocrinol. 2002;16(7):1590-1597.12089353
11. Kimura I, Yoshikawa M, Kobayashi S, et al. New triterpenes, myrrhanol A and myrrhanone A, from guggul-gum resins, and their potent anti-inflammatory effect on adjuvant-induced air-pouch granuloma of mice. Bioorg Med Chem Lett. 2001;11(8):985-989.11327606
12. Su SL, Duan JA, Tang YP, et al. Isolation and biological activities of neomyrrhaol and other terpenes from the resin of Commiphora myrrha. Planta Med. 2009;75(4):351-355.19101885
13. Ahmed R, Ali Z, Wu Y, et al. Chemical characterization of a commercial Commiphora wightii resin sample and chemical profiling to assess for authenticity. Planta Med. 2011;77(9):945-950.21240842
14. Sumantran VN, Kulkarni AA, Harsulkar A, et al. Hyaluronidase and collagenase inhibitory activities of the herbal formulation Triphala guggulu. J Biosci. 2007;32(4):755-761.17762148
15. Francis JA, Raja SN, Nair MG. Bioactive terpenoids and guggulusteroids from Commiphora mukul gum resin of potential anti-inflammatory interest. Chem Biodivers. 2004;1(11):1842-1853.17191820
16. Rahimi R, Shams-Ardekani MR, Abdollahi M. A review of the efficacy of traditional Iranian medicine for inflammatory bowel disease. World J Gastroenterol. 2010;16(36):4504-4514.20857519
17. Song JJ, Kwon SK, Cho CG, Park SW, Chae SW. Guggulsterone suppresses LPS induced inflammation of human middle ear epithelial cells (HMEEC). Int J Pediatr Otorhinolaryngol. 2010;74(12):1384-1387.20971513
18. Manjula N, Gayathri B, Vinaykumar KS, Shankernarayanan NP, Vishwakarma RA, Balakrishnan A. Inhibition of MAP kinases by crude extract and pure compound isolated from Commiphora mukul leads to down regulation of TNF-alpha, IL-1beta and IL-2. Int Immunopharmacol. 2006;6(2):122-132.16399617
19. Duwiejua M, Zeitlin IJ, Waterman PG, Chapman J, Mhango GJ, Provan GJ. Anti-inflammatory activity of resins from some species of the plant family Burseraceae. Planta Med. 1993;59(1):12-16.8441773
20. Sharma JN, Sharma JN. Comparison of the anti-inflammatory activity of Commiphora mukul (an indigenous drug) with those of phenylbutazone and ibuprofen in experimental arthritis induced by mycobacterial adjuvant. Arzneimittelforschung. 1977;27(7):1455-1457.578471
21. Khanna D, Sethi G, Ahn KS, et al. Natural products as a gold mine for arthritis treatment. Curr Opin Pharmacol. 2007;7(3):344-351.17475558
22. Mencarelli A, Renga B, Palladino G, Distrutti E, Fiorucci S. The plant sterol guggulsterone attenuates inflammation and immune dysfunction in murine models of inflammatory bowel disease. Biochem Pharmacol. 2009;78(9):1214-1223.19555671
23. Kalariya NM, Shoeb M, Reddy AB, Zhang M, van Kuijk FJ, Ramana KV. Prevention of endotoxin-induced uveitis in rats by plant sterol guggulsterone. Invest Ophthalmol Vis Sci. 2010;51(10):5105-5113.20435582
24. Singh BB, Mishra LC, Vinjamury SP, Aquilina N, Singh VJ, Shepard N. The effectiveness of Commiphora mukul for osteoarthritis of the knee: an outcomes study. Altern Ther Health Med. 2003;9(3):74-79.12776478
25. Macha MA, Matta A, Chauhan SS, Siu KW, Ralhan R. Guggulsterone targets smokeless tobacco induced PI3K/Akt pathway in head and neck cancer cells. PLoS One. 2011;6(2):e14728.21383988
26. Shishodia S, Sethi G, Ahn KS, Aggarwal BB. Guggulsterone inhibits tumor cell proliferation, induces S-phase arrest, and promotes apoptosis through activation of c-Jun N-terminal kinase, suppression of Akt pathway, and downregulation of antiapoptotic gene products. Biochem Pharmacol. 2007;74(1):118-130.17475222
27. Leeman-Neill RJ, Wheeler SE, Singh SV, et al. Guggulsterone enhances head and neck cancer therapies via inhibition of signal transducer and activator of transcription-3. Carcinogenesis. 2009;30(11):1848-1856.19762335
28. Xiao D, Singh SV. z-Guggulsterone, a constituent of Ayurvedic medicinal plant Commiphora mukul, inhibits angiogenesis in vitro and in vivo. Mol Cancer Ther. 2008;7(1):171-80.18202020
29. Singh SV, Zeng Y, Xiao D, et al. Caspase-dependent apoptosis induction by guggulsterone, a constituent of Ayurvedic medicinal plant Commiphora mukul, in PC-3 human prostate cancer cells is mediated by Bax and Bak. Mol Cancer Ther. 2005;4(11):1747-1754.16275996
30. Singh SV, Choi S, Zeng Y, Hahm ER, Xiao D. Guggulsterone-induced apoptosis in human prostate cancer cells is caused by reactive oxygen intermediate dependent activation of c-Jun NH2-terminal kinase. Cancer Res. 2007;67(15):7439-7449.17671214
31. Xiao D, Zeng Y, Prakash L, Badmaev V, Majeed M, Singh SV. Reactive oxygen species-dependent apoptosis by gugulipid extract of Ayurvedic medicine plant Commiphora mukul in human prostate cancer cells is regulated by c-Jun N-terminal kinase. Mol Pharmacol. 2011;79(3):499-507.21115635
32. Sarfaraz S, Siddiqui IA, Syed DN, Afaq F, Mukhtar H. Guggulsterone modulates MAPK and NF-kappaB pathways and inhibits skin tumorigenesis in SENCAR mice. Carcinogenesis. 2008;29(10):2011-2018.18684729
33. Ichikawa H, Aggarwal BB. Guggulsterone inhibits osteoclastogenesis induced by receptor activator of nuclear factor-kappaB ligand and by tumor cells by suppressing nuclear factor-kappaB activation. Clin Cancer Res. 2006;12(2):662-668.16428513
34. Ojha SK, Nandave M, Arora S, et al. Effect of Commiphora mukul extract on cardiac dysfunction and ventricular function in isoproterenol-induced myocardial infarction. Indian J Exp Biol. 2008;46(9):646-652.18949894
35. Kaul S, Kapoor NK. Cardiac sarcolemma enzymes and liver microsomal cytochrome P450 in isoproterenol treated rats. Indian J Med Res. 1989;90:62-68.2722218
36. Miller AL. Botanical influences on cardiovascular disease. Altern Med Rev. 1998;3(6):422-431.9855567
37. Bordia A, Chuttani SK. Effect of gum guggulu on fibrinolysis and platelet adhesiveness in coronary heart disease. Indian J Med Res. 1979;70:992-996.396237
38. Sharma B, Salunke R, Srivastava S, Majumder C, Roy P. Effects of guggulsterone isolated from Commiphora mukul in high fat diet induced diabetic rats. Food Chem Toxicol. 2009;47(10):2631-2639.19635521
39. Cornick CL, Strongitharm BH, Sassano G, et al. Identification of a novel agonist of peroxisome proliferator-activated receptors alpha and gamma that may contribute to the anti-diabetic activity of guggulipid in Lep(ob)/Lep(ob) mice. J Nutr Biochem. 2009;20(10):806-815.18926687
40. Bhatt AD, Dalal DG, Shah SJ, et al. Conceptual and methodologic challenges of assessing the short-term efficacy of Guggulu in obesity: data emergent from a naturalistic clinical trial. J Postgrad Med. 1995;41(1):5-7.10740691
41. Panda S, Kar A. Guggulu (Commiphora mukul) potentially ameliorates hypothyroidism in female mice. Phytother Res. 2005;19(1):78-80.15798994
42. Tripathi YB, Malhotra OP, Tripathi SN. Thyroid stimulating action of Z-guggulsterone obtained from Commiphora mukul. Planta Med. 1984;50(1):78-80.17340256
43. Burris TP, Montrose C, Houck KA, et al. The hypolipidemic natural product guggulsterone is a promiscuous steroid receptor ligand. Mol Pharmacol. 2005;67(3):948-954.15602004
44. Brobst DE, Ding X, Creech KL, Goodwin B, Kelley B, Staudinger JL. Guggulsterone activates multiple nuclear receptors and induces CYP3A gene expression through the pregnane X receptor. J Pharmacol Exp Ther. 2004;310(2):528-535.15075359
45. Khanna N, Arora D, Halder S, et al. Comparative effect of Ocimum sanctum, Commiphora mukul, folic acid and ramipril on lipid peroxidation in experimentally-induced hyperlipidemia. Indian J Exp Biol. 2010;48(3):299-305.21046985
46. Yu BZ, Kaimal R, Bai S, et al. Effect of guggulsterone and cembranoids of Commiphora mukul on pancreatic phospholipase A(2): role in hypocholesterolemia. J Nat Prod. 2009;72(1):24-28.19102680
47. Nityanand S, Srivastava JS, Asthana OP. Clinical trials with gugulipid. A new hypolipidaemic agent. J Assoc Physicians India. 1989;37(5):323-328.2693440
48. Singh RB, Niaz MA, Ghosh S. Hypolipidemic and antioxidant effects of Commiphora mukul as an adjunct to dietary therapy in patients with hypercholesterolemia. Cardiovasc Drugs Ther. 1994;8(4):659-664.7848901
49. Thompson Coon JS, Ernst E. Herbs for serum cholesterol reduction: a systematic review. J Fam Pract. 2003;52(6):468-478.12791229
50. Sahni S, Hepfinger CA, Sauer KA. Guggulipid use in hyperlipidemia: case report and review of the literature. Am J Health Syst Pharm. 2005;62(16):1690-1692.16085931
51. Szapary PO, Wolfe ML, Bloedon LT, et al. Guggulipid for the treatment of hypercholesterolemia: a randomized controlled trial. JAMA. 2003;290(6):765-772.12915429
52. Hasani-Ranjbar S, Nayebi N, Moradi L, Mehri A, Larijani B, Abdollahi M. The efficacy and safety of herbal medicines used in the treatment of hyperlipidemia; a systematic review. Curr Pharm Des. 2010;16(26):2935-2947.20858178
53. Nohr LA, Rasmussen LB, Straand J. Resin from the mukul myrrh tree, guggul, can it be used for treating hypercholesterolemia? A randomized, controlled study. Complement Ther Med. 2009;17(1):16-22.19114224
54. Shields KM, Moranville MP. Guggul for hypercholesterolemia. Am J Health Syst Pharm. 2005;62(10):1012-1014.15901582
55. Thappa DM, Dogra J. Nodulocystic acne: oral gugulipid versus tetracycline. J Dermatol. 1994;21(10):729-731.7798429
56. Singh R, Arya RC, Minhas SS, Dutt A. A comparative study of Barron's rubber band ligation with Kshar Sutra ligation in hemorrhoids. Int J Ayurveda Res. 2010;1(2):73-81.20814519
57. Chauhan CK, Joshi MJ, Vaidya AD. Growth inhibition of struvite crystals in the presence of herbal extract Commiphora wightii. J Mater Sci Mater Med. 2009;20 (suppl 1):S85-S92.18568390
58. Raut AA, Sunder S, Sarkar S, Pandita NS, Vaidya AD. Preliminary study on crystal dissolution activity of Rotula aquatica, Commiphora wightii and Boerhaavia diffusa extracts. Fitoterapia. 2008;79(7-8):544-547.18644427
59. Bianchi A, Cantú P, Firenzuoli F, Mazzanti G, Menniti-Ippolito F, Raschetti R. Rhabdomyolysis caused by Commiphora mukul, a natural lipid-lowering agent. Ann Pharmacother. 2004;38(7-8):1222-1225.15187214
60. Dalvi SS, Nayak VK, Pohujani SM, Desai NK, Kshirsagar NA, Gupta KC. Effect of gugulipid on bioavailability of diltiazem and propranolol. J Assoc Physicians India. 1994;42(6):454-455.7852226
61. Antarkar DS, Pande R, Athavale AV, et al. Phase I tolerability study of Yogaraj-guggulua-popular ayurvedic drug. J Postgrad Med. 1984;30(2):111-115.6527293
62. Gelfand JM, Crawford GH, Brod BA, Szazpary PO. Adverse cutaneous reactions to guggulipid. J Am Acad Dermatol. 2005;52(3, pt 1):533-534.15761442
63. Salavert M, Amarger S, Le Bouedec MC, Roger H, Souteyrand P, D'incan M. Allergic contact dermatitis to guggul in a slimming cream. Contact Dermatitis. 2007;56(5):286-287.17441853
64. Kölönte A, Guillot B, Raison-Peyron N. Allergic contact dermatitis to guggul extract contained in an anticellulite gel-cream. Contact Dermatitis. 2006;54(4):226-227.16650108
65. Grieco A, Miele L, Pompili M, et al. Acute hepatitis caused by a natural lipid-lowering product: when "alternative" medicine is no "alternative" at all. J Hepatol. 2009;50(6):1273-1277.19398239
66. Yellapu RK, Mittal V, Grewal P, Fiel M, Schiano T. Acute liver failure caused by fat burners' and dietary supplements: a case report and literature review. Can J Gastroenterol. 2011;25(3):157-160.21499580
67. Hasani-Ranjbar S, Nayebi N, Moradi L, Mehri A, Larijani B, Abdollahi M. The efficacy and safety of herbal medicines used in the treatment of hyperlipidemia; a systematic review. Curr Pharm Des. 2010;16(26):2935-2947.20858178
68. Rastogi S, Pandey MM, Rawat AK. Traditional herbs: a remedy for cardiovascular disorders. Phytomedicine. 2016;23(11):1082-1089.26656228
69. Farooqui AA, Farooqui T, Madan A, Ong JH, Ong WY. Ayurvedic medicine for the treatment of dementia: mechanistic aspects. Evid Based Complement Alternat Med. 2018;2018:2481076.29861767

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

Copyright © 2025 Wolters Kluwer Health